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Gensini scoreAbstract Background: Several studies showed that ST-segment elevation myocardial infarction
(STEMI) patients with high body mass index (BMI) have better in-hospital outcomes.
Aim: This study examined the impact of waist circumference (WC) on the hospital outcome and
coronary angiographic extent of STEMI patients.
Methods: We evaluated 142 consecutive patients with STEMI. Patients were classiﬁed into 2
groups according to WC. Group A (n= 72) had increased WC (WC> 88/102 cm for women/
men). Group B (n= 70) had normal WC. A primary composite outcome of in-hospital mortality
and cardiovascular complications namely heart failure, cardiogenic shock, serious arrhythmias,
re-infarction, post infarction angina, a secondary outcome of in-hospital mortality and coronary
angiographic ﬁndings were compared between the 2 groups.
Results: Group A patients were signiﬁcantly older, had a signiﬁcantly higher prevalence of hyper-





160 S.W.G. Bakhoum et al.group B. There was no statistically signiﬁcant difference in the primary outcome between the 2
groups. WC as a categorical or as a continuous variable did not have any signiﬁcant inﬂuence
on the secondary outcome of in-hospital mortality even after adjustment for other predictors of
death. Age was the only statistically signiﬁcant predictor for mortality (p= 0.01). Coronary angi-
ography revealed no statistically signiﬁcant difference in the number of diseased coronary vessels,
number of coronary lesions or Gensini score between the 2 groups.
Conclusion: A high WC, had no favorable impact on in-hospital mortality, cardiovascular compli-
cations or coronary angiographic extent in STEMI patients.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Obesity, a worldwide epidemic in recent years, is amajor predic-
tor of fatal and nonfatal cardiovascular events.1,2 Different re-
ports have however, shown an apparent protective effect of
obesity as reﬂected by a high body mass index (BMI) on out-
come of patients with coronary artery disease (CAD) and pa-
tients with acute coronary syndromes (ACS), the concept of
the ‘‘obesity paradox’’. Ikeda et al.3 studying the impact of
obesity on the long term prognosis of patients with ﬁrst acute
myocardial infarction (AMI) have shown that patients with
higher BMI and no insulin resistance or diabetes mellitus
(DM) presented better long term outcomes while normal weight
patients with DM presented the highest risk of major cardiac
and cerebrovascular events. A recent report of the Swedish cor-
onary angiography and angioplasty registry4 concluded that the
relation between BMI and mortality was U-shaped in patients
who underwent coronary angiography due to ACS, with the na-
dir among overweight or obese patients while underweight and
normal-weight patients had the highest risk.
Abdominal adiposity, a reﬂection of central body fat distri-
bution, is associated with signiﬁcant metabolic abnormalities
including insulin resistance, hyperinsulinemia, elevated triglyc-
erides, glucose intolerance, DM5,6 as well increased incidence
of hypertension (HTN), atherosclerosis and strokes.7–9 Waist
circumference, a simple measure to calculate, is a surrogate
marker of abdominal fat.10 Fewer studies have however exam-
ined the impact of waist circumference on clinical outcome
after acute coronary events. A large study by Zeller et al.11
evaluating patients with AMI has shown that WC as a contin-
uous variable had no impact on all-cause death. After adjust-
ment for baseline confounding predictors of death, BMI also
was not independently predictive of death. The aim of this
study was to assess the impact of abdominal adiposity as re-
ﬂected by waist circumference on the in-hospital outcome
and coronary angiographic ﬁndings of a cohort of Egyptian
patients with STEMI and to determine whether these ﬁndings
are independent of total obesity or BMI.2. Materials and methods
2.1. Patients
In this prospective study, patients presenting with acute STE-
MI were included. Data were collected from a cohort of 142
consecutive patients admitted to the coronary care unit of
Kasralaini University Hospital, Cairo University, during the
period between August 2011 and April 2012. The diagnosis
of STEMI was based on the universal deﬁnition of myocardialinfarction.12 The present study complied with the Declaration
of Helsinki and was approved by the ethics committee of Kasr-
alaini University Hospital, Cairo University. Each patient gave
a written consent before enrollment in the study.
2.1.1. Data collection
Data on demographics, CV risk factors (history of HTN, DM,
treated hyperlipidemia, current smoking, family history of
CAD), prior MI, prior PCI or CABG were collected prospec-
tively, along with admission characteristics, chronic medication
intake prior to admission and hemodynamic parameters. The
type of acute reperfusion procedures (thrombolysis or PCI)
was also recorded. Anthropometric parameters were measured
within 24 h of admission. BMI was categorized according to the
World Health Organization standards13 as normal (<25 kg/
m2), overweight (25–29.9 kg/m2), obese (30–34.9 kg/m2), and
very obese (P35 kg/m2). WC was measured with a non-elastic
tape at the mid distance between the top of the iliac crest and
the bottomof the rib cage and as the average of 2measurements,
one taken after inspiration and the other after expiration. In-
creased WC was deﬁned using the National Cholesterol Educa-
tion Program Adult Treatment Panel III (NCEP ATP)14 cutoff
of WC> 102 cm in men and >88 cm in women.
2.2. Methods
The patients were subjected to the following examinations.
2.2.1. Electrocardiogram (ECG)
New ST elevation at the J-point in two contiguous leads with
the cut-off points:P0.2 mV in men orP0.15 mV in women in
leads V2–V3 and/orP0.1 mV in other leads or new left bundle
branch block were considered diagnostic of STEMI in the
presence of a rise and/or fall of cardiac biomarkers with at
least one value above the 99th percentile of the upper reference
level.12
2.2.2. Echocardiography
M-mode, two dimensional echocardiography and Doppler
examinations were performed within 48 h of admission to ob-
tain the following variables according to the recommendations
of the American society of echocardiography:15
(a) M-mode measurements: the end systolic dimension of
the left atrium (LA), the end diastolic dimension of the
aortic root (Ao), the left ventricular end diastolic
diameter (LVEDD), the left ventricular end systolic
diameter (LVESD), the end diastolic posterior wall
thickness(PWT) and septal wall thickness (SWT).
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Simpson’s method in the apical four-chamber and
two-chamber views.
(c) Wall motion score index (WMSI): We used a 16 segment
model; each segment was assigned a score, based on its
contractility as assessed visually: normal: (1) hypokine-
sis, (2) akinesis, (3) dyskinesis, (4) and aneurysm (5).
WMSI was calculated as the sum of wall motion scores
divided by the number of the interpreted segments.
(d) Transmitral, transaortic and transtricuspid Doppler
ﬂows were also recorded.
2.2.3. Coronary angiography
The patients were subjected to coronary angiography for pri-
mary percutaneous coronary intervention or within 24 h after
thrombolytic therapy as recommended by the European Soci-
ety of Cardiology.16 Four patients in each of the studied
groups were neither subjected to primary PCI nor received
thrombolytic therapy because of late presentation after onset
of MI. These patients received medical treatment and were
subjected to coronary angiography within 24 h of presentation.
Signiﬁcant lesions of the coronary arteries were deﬁned as
those with P70% diameter narrowing (P50% for the left
main coronary artery). The following variables were collected
from the coronary angiogram:
a. The number of diseased coronary vessels.
b. The number of signiﬁcant lesions.
c. The Gensini score17 was calculated for each patient by
assigning a severity score to each coronary stenosis
according to the degree of luminal narrowing and its
geographic importance. Reduction in the lumen diame-
ter, and the roentgenographic appearance of concentric
lesions and eccentric plaques were evaluated (reductions
of 25%, 50%, 75%, 90%, and 99%, and complete occlu-
sion were given Gensini scores of 1, 2, 4, 8, 16, and 32,
respectively). Each principal vascular segment was
assigned a multiplier in accordance with the functional
signiﬁcance of the myocardial area supplied by that
segment: the left main coronary artery · 5; the proximal
segment of left anterior descending coronary
artery · 2.5; the proximal segment of the circumﬂex
artery · 2.5; the mid-segment of the LAD · 1.5; the right
coronary artery, the distal segment of the LAD, the pos-
terolateral artery and the obtuse marginal artery · 1;
and others · 0.5. Scoring was performed by two observ-
ers (SB and ME) independently and averaged.
2.2.4. In-hospital outcome
Data on in-hospital complications and mortality were col-
lected. The primary outcome of interest was a composite of
in-hospital mortality, and in-hospital cardiovascular complica-
tions, which may have included any of the following outcomes:
heart failure, cardiogenic shock, serious arrhythmias, re-infarc-
tion, or post infarction angina. The secondary outcome of the
study was in-hospital mortality. Heart failure was deﬁned as
rales over more than half of the lung ﬁeld (Killip class II), or
pulmonary edema (Killip class III). Cardiogenic shock (Killip
class IV)18 was deﬁned as persistent hypotension (systolicblood pressure <80 mmHg) with signs of hypoperfusion as
manifest clinically by cool extremities, decreased urine output,
and/or alteration in mental status.19 Serious arrhythmias were
deﬁned as arrhythmias requiring treatment. Re-infarction was
deﬁned in the ﬁrst 18 h after the start of drug administration
by recurrent signs and symptoms of ischemia at rest accompa-
nied by new or recurrent ST-segment elevations of 0.1 mV in at
least 2 contiguous leads that persisted for at least 30 min. After
18 h, reinfarction was deﬁned by the appearance of new Q
waves (by Minnesota Code Criteria) inP2 leads, new left bun-
dle branch block, and/or enzyme evidence of reinfarction,
which was deﬁned as re-elevation of creatine kinase-MB
(CK-MB) to above the upper limit of normal and increased
by P50% over the previous value.20 Post infarction angina
was deﬁned as recurrence of angina from 24 h after MI until
hospital discharge.
3. Statistical analysis
Data entry and statistical analysis were done using SPSS under
windows, version 18. Chi square test was used in order to de-
tect the difference in frequency for categorical variables. Fish-
er’s exact test was used, instead of chi square test, when there
was a cell in the 2 · 2 table with an expected frequency below
5. t-test was used to assess the difference between two means of
continuous variables. Multivariate logistic analysis was done
to predict the relation between WC, and in-hospital mortality
after adjustment for BMI and other cardiovascular risk fac-
tors. All tests were 2-sided and a P value <0.05 was considered
statistically signiﬁcant.
4. Results
4.1. Patient baseline characteristics: Table 1
A total of 142 STEMI patients were included in the study.
Patients were divided into two groups according to waist cir-
cumference: Group A: included 72 patients with abdominal
obesity deﬁned as waist circumference >102 cm in males,
and >88 cm in females. Group B: included 70 patients without
abdominal obesity deﬁned as waist circumference 6102 cm in
males, and 688 cm in females.
Patients of group A were signiﬁcantly older than patients of
group B. (p= 0.048). The number of male patients in group A
was signiﬁcantly less than in group B (p< 0.001).The mean
body mass index in Group A was signiﬁcantly higher than in
group B (p< 0.007). The prevalence of HTN and DM was sig-
niﬁcantly higher (p< 0.001 both) while current smoking was
signiﬁcantly lower in Group A compared to group B.
(p= 0.002) A family history of CAD was similar in both
groups. A signiﬁcantly larger proportion of patients in group
A were already on aspirin and statins on admission compared
to group B (p= 0.008 and 0.04, respectively). The other med-
ications including b-blockers, ACE-Is/ARBs, and clopidogrel
were prescribed similarly in both groups. A prior history of
MI, PCI, CABG, or stroke was similar in both groups. There
was no statistically signiﬁcant difference between the 2 groups
as regards type of acute revascularization on admission
(thrombolytic therapy versus primary PCI). Four patients of
each group received medical treatment as they presented late
out of time window for immediate revascularization.
Table 1 Demographic and clinical characteristics of the study population on admission.
Variable Group A n (72) Group B n (70) P value
Age (year) mean ± SD 56.8 ± 11.2 53.1 ± 10.6 0.048
Males/females n (%) 37/35 (51.4/48.6) 67/3 (95.7/4.3) <0.001
Body mass index (kg/m2) mean ± SD 34 ± 5.1 25.8 ± 2.7 0.007
Acute revascularization by thrombolysis n (%) 57(79.2) 50(71.4) 0.5
Acute revascularization by primary PCI n (%) 11(15.3) 16(22.9)
Medical treatment n (%) 4(5.5) 4(5.7)
Risk factors
Hypertension n (%) 41(56.9) 18(25.7) <0.001
Diabetes mellitus n (%) 38(52.8) 15(21.4) <0.001
Current smoking n (%) 26(36.1) 44(62.9) 0.002
Family history of coronary artery disease n (%) 9(12.5) 14(20) 0.2
Chronic medications prior to admission
Acetylsalicylic acid n (%) 24(33.3) 10(14.3) 0.008
Statins n (%) 10(13.9) 3(4.3) 0.04
beta-blockers n (%) 11(15.3) 4(5.7) 0.06
Clopidogrel n (%) 1 (1.4) 0(0) 1
ACEIs/ARBs n (%) 9(12.5) 4(5.7) 0.1
Past history
Prior MI n (%) 9(12.5%) 11(15.7%) 0.5
Prior PCI i (%) 5(6.9%) 6(8.6%) 0.7
Prior CABG n (%) 2(2.8%) 0(0%) 0.4
Prior stroke n (%) 3(4.2%) 5(7.1%) 0.4
ACEIs: angiotensin converting enzyme inhibitors, ARBs: angiotensin receptor blockers, MI: myocardial infarction, PCI: percutaneous coronary
intervention, CABG: coronary artery bypass grafting.
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Table 2
There was no statistically signiﬁcant difference between the 2
groups as regards MI territory. Forty-one patients in group A
had STEMI in the anterior territory compared to forty-nine
patients in group B.
There was no statistically signiﬁcant difference in LAD,
AoD, LVEDD, LVESD, SWT, and PWT echocardiographic
dimensions, EF or WMSI between the 2 groups.
4.3. Coronary angiographic ﬁndings Table 2
There was no statistically signiﬁcant difference in the number
of diseased vessels, the number of coronary lesions or the
Gensini score between the 2 groups.
4.4. In-hospital clinical outcome Table 3
There was no statistically signiﬁcant difference in the primary
composite end point of in-hospital mortality and/or cardiovas-
cular complications between the 2 groups. There was also no
statistically signiﬁcant difference in the incidence of any of
the cardiovascular complications namely heart failure (Killip
class II), pulmonary edema (Killip class III) or cardiogenic
shock (Killip class IV), occurrence of serious arrhythmias,
re-infarction or post-infarction angina between the 2 groups.
As regards the secondary in-hospital outcome of in-hospital
mortality, a lower death rate was observed in group A (3/72)
compared to group B (6/70), but this difference did not
reach statistical signiﬁcance. Even after multivariate regressionanalysis adjusting for age, gender, BMI, HTN, DM, family
history of CAD, and smoking status, age was the only statisti-
cally signiﬁcant predictor for mortality (adjusted odds ratio:
1.13; p= 0.01) (Table 4). Correlation between WC or BMI
as continuous variables and in-hospital mortality were also
not statistically signiﬁcant (Table 5).5. Discussion
In the present study, WC was found to have no impact on the
primary composite outcome of in-hospital mortality and/or
cardiovascular complications. WC as a categorical or as a con-
tinuous variable did not also have any signiﬁcant inﬂuence on
the secondary outcome of in-hospital mortality even after
adjustment for other predictors of death: age, gender, BMI,
HTN, DM, FH of CAD, and smoking status in patients pre-
senting with STEMI.
These ﬁndings do not support the concept of ‘‘obesity par-
adox’’ which was reported in several studies to describe a pro-
tective effect of a high BMI on survival in ACS patients. In the
GUSTO trial,21 both height and weight were found to be in-
versely associated with 30-day mortality among STEMI pa-
tients treated with ﬁbrinolytic therapy. A large retrospective
analysis of STEMI patients from seven clinical trials per-
formed by Mehta et al.22 showed that weight, BMI, and body
surface area (BSA) were inversely and independently related to
all clinical events. The prognostic information contributed by
weight beyond that conferred by baseline characteristics was
however minimal making it of limited clinical relevance for
predicting 30-day death and in-hospital cardiogenic shock.
Analysis of data of 10,534 STEMI patients of the German
Table 3 Comparison of incidence of primary composite outcome, its components, and secondary outcome in group A and group B
patients.
Variable Group A (n= 72) Group B (n= 70) P value
Primary composite outcome n (%) 22(30.6) 20(28.6) 0.7
Congestive heart failure n (%) 5(6.9) 5(7.1) 1
Cardiogenic shock n (%) 4(5.6) 3(4.3) 1
Serious arrhythmias n (%) 14(19.4) 12(17.1) 0.7
Reinfarction n (%) 0 (0) 1(1.4) 0.4
Post MI angina n (%) 6(8.3) 6(8.6) 0.9
Secondary outcome (death) n (%) 3(4.2) 6(8.6) 0.3
Table 4 Logistic regression analysis of predictors of mortality
in the whole studied population.
Independent variables Adjusted OR 95% C.I. P value
Age 1.13 1.03–1.26 0.013*
Male gender 0.31 0.02–4.41 0.389
Hypertension 2.70 0.32–22.38 0.357
DM 2.35 0.26–21.15 0.447
Smoking 2.642 0.34–20.54 0.353
Family history of CAD 8.6 0.5–148.8 0.137
Obesity by BMI 0.184 0.01–2.9 0.228
Obesity by WC 0.374 0.01–5.0 0.374
OR: odds ratio, CI: Conﬁdence interval.
* Signiﬁcant.
Table 5 Correlation between WC, BMI as continuous vari-
ables and mortality.
Independent variables Adjusted OR 95% C.I. P value
WC 0.96 0.91–1.02 0.166
BMI 0.88 0.75–1.03 0.106
OR: odds ratio, CI: Conﬁdence interval.
Table 2 Electrocardiographic, echocardiographic and coronary angiographic ﬁndings.
Electrocardiographic ﬁndings Group A n (72) Group B n (70) P value
Territory of myocardial infarction anterior/non anterior n (%) 41/31 (56.9/43.1) 49/21 (70/30) 0.08
Echocardiographic ﬁndings
LVEDD (cm) 5.6 ± 0.64 5.5 ± 0.68 0.4
LVESD (cm) 4.08 ± 0.78 4.14 ± 0.79 0.7
EF (%) 50.8 ± 12.17 47.3 ± 12.61 0.1
WMSI 1.5 ± 0.34 1.52 ± 0.38 0.7
Diastolic dysfunction n (%) 40(69) 37 (61.7) 0.4
Coronary angiographic ﬁndings
Number of diseased vessels 1.9 + 1.2 2.1 + 1.2 0.2
Number of lesions 2.1 + 1.4 2.3 + 1.5 0.2
Gensini score 85.1 + 38.5 60.4 + 43.6 0.8
 Anterior MI included anterior, antero-septal and extensive anterior infarctions. Non anterior MI included inferior, posterior and lateral
infarctions. LVEDD: left ventricular end diastolic dimensions; LVESD: left ventricular end systolic dimensions; EF: ejection fraction; WMSI:
wall motion score index.
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younger age in obese patients (BMIP 30 kg/m2), who eventu-
ally showed the lowest hospital and long-term mortality of all
compared BMI-groups. A recent study4 extracting data from
the Swedish coronary angiography and angioplasty registry
of patients undergoing coronary angiography due to ACS,
has reported that the relation between BMI and mortality
was U-shaped, with the nadir among overweight or obese pa-
tients and underweight and normal-weight patients having the
highest risk. In this study, obese patients were more likely to be
younger, have hyperlipidemia, HTN, DM and had less severeCAD at the time of cardiac catheterization. The large popula-
tion-based APPROACH study24 has shown that mildly or
moderately obese patients with established CAD had reduced
mortality compared with normal BMI patients whether treated
by medical management only, PCI or CABG. They could not
demonstrate that the obese patients were being more aggres-
sively treated with statins, b-blockers, ACE-I or nitrates. In
our study, a signiﬁcantly larger proportion of patients in group
A were already on aspirin and statins on admission compared
to group B while the other disease modifying medications
b-blockers and ACE-Is/ARBs were prescribed similarly in
both groups. This obesity paradox noted in the APPROACH
study was explained by the fact that compared with normal
weight patients, obese patients were younger and less likely
to have high-risk coronary anatomy or high percentage of
myocardium at risk at the time of cardiac catheterization.
The younger age at MI presentation in obese patients was in
164 S.W.G. Bakhoum et al.fact reported in several studies.25–27 In our study, which could
not demonstrate this obesity paradox, the high WC group A
patients were signiﬁcantly older, were having a similar coro-
nary anatomy, and similar echocardiographically estimated
EF and wall motion score index reﬂecting the amount of myo-
cardium at jeopardy, compared to group B patients. The high-
er prevalence of HTN and DM in group A compared to group
B could also explain the lack of better clinical outcome in pa-
tients with high WC in our study. Coronary angiography done
to all the patients revealed no statistically signiﬁcant difference
in the number of diseased vessels, the number of coronary le-
sions or the Gensini score between the 2 groups. These ﬁndings
are again discordant with the results of several studies. Niraj
et al.28 studying the severity of CAD in obese patients showed
a negative correlation between BMI and age as well as between
BMI and Duke jeopardy coronary angiographic score indicat-
ing that patients with higher BMI were referred for coronary
angiography at a younger age, and had a lower coronary bur-
den. Rubinshtein et al.29 examined the relation between BMI
and frequency of high-risk coronary anatomy (HRCA) deﬁned
asP 50% stenosis of the left main coronary artery and/or sig-
niﬁcant (P70% narrowing) 3-vessel CAD. HRCA was present
less often in obese patients.
The results of our study were however, in agreement with
the study by Zeller et al. 2008,11 who showed that neither
BMI nor WC independently predicted death after acute MI.
In this study, despite an apparent obesity paradox demon-
strated by a reduced death rate associated with an increased
BMI, this ﬁnding did not remain signiﬁcant after adjustment
for baseline predictors of death. WC as a continuous variable
had no impact on all cause death either. For both sexes, a
worse outcome was observed in a subgroup of high-risk pa-
tients i.e., those with a high WC and a low BMI, which pre-
sumably reﬂects the presence of visceral obesity and a low
muscle mass. In our study, the group with a high WC had a
high BMI as well (mean: 34 kg/m2) and when BMI was in-
cluded in a multivariate analysis model as a predictor of death,
neither WC nor BMI correlated with in-hospital mortality.
Age was the only statistically signiﬁcant predictor for mortality
in our study. De Koning et al.30 in a meta-regression analysis
of 15 prospective studies, demonstrated that the risk of inci-
dent cardiovascular disease increases in men and women with
elevations in WC or waist to hip ratio (WHR) even after
adjusting for age and cohort characteristics. WC appears to
promote insulin resistance, dyslipidaemia, and HTN31,32 and
to be more strongly associated with incident cardiovascular
events, and death.33,34 All these data on the risks associated
with visceral obesity could explain the ﬁndings of our study
which could not record any advantage of a high WC on clinical
outcome in STEMI patients.
6. Limitations
The main limitation of our study, is the relatively small num-
ber of patients as we only included STEMI patients who were
subjected to coronary angiography within their hospital stay.
The second limitation of this study, was the fact that most of
our patients with high WC had also a high BMI; we could
not then separate the effect of either factor separately on the
ﬁnal results. A third limitation is the observational nature of
this study. Analysis of the data provides associative ratherthan a causative correlation between WC and the studied
variables.
7. Conclusion
A high WC, did not have a favorable impact on clinical out-
come and consequently did not support the phenomenon of
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